LALF(32‐51)‐E7, a HPV‐16 therapeutic vaccine candidate, forms protein body‐like structures when expressed in Nicotiana benthamiana leaves

High‐risk human papillomaviruses (HPVs) cause cervical cancer, and while there are good prophylactic vaccines on the market, these are ineffective against established infections, creating a clear need for therapeutic vaccines. The HPV E7 protein is one of the essential oncoproteins for the onset and...

Descripción completa

Detalles Bibliográficos
Autores principales: Yanez, Romana J. R., Lamprecht, Renate, Granadillo, Milaid, Torrens, Isis, Arcalís, Elsa, Stöger, Eva, Rybicki, Edward P., Hitzeroth, Inga I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787834/
https://www.ncbi.nlm.nih.gov/pubmed/28733985
http://dx.doi.org/10.1111/pbi.12802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787834/
https://www.ncbi.nlm.nih.gov/pubmed/28733985
http://dx.doi.org/10.1111/pbi.12802

Ejemplares similares